Literature DB >> 1768386

Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis.

B R Dannemann1, D M Israelski, G S Leoung, T McGraw, J Mills, J S Remington.   

Abstract

In order to further characterize the pathogenesis of Toxoplasma gondii infection in patients with AIDS and AIDS-related complex (ARC), a cohort of HIV- and Toxoplasma-infected individuals were identified and prospectively followed. Four hundred and 10 HIV-infected individuals followed in the San Francisco General Hospital AIDS Clinic were screened for antibodies to Toxoplasma between November 1986 and November 1988. Of the 67 (16%) individuals seropositive for Toxoplasma antibodies, 33 (49%) were followed monthly for a mean duration of 7.5 months. One hundred and 11 follow-up blood samples were obtained in order to determine Toxoplasma serology and the incidence of parasitemia. In general, Toxoplasma immunoglobulin (Ig) G antibodies remained stable over time. Detection of Toxoplasma antigenemia and parasitemia was uniformly negative, including those specimens obtained from two individuals within 45 days of their developing toxoplasmic encephalitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768386     DOI: 10.1097/00002030-199111000-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting.

Authors:  D Aubert; F Foudrinier; I Villena; J M Pinon; M F Biava; E Renoult
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection.

Authors:  D G Johns; M J Gill
Journal:  Can J Infect Dis       Date:  1998-07

4.  Optimization and evaluation of a PCR assay for detecting toxoplasmic encephalitis in patients with AIDS.

Authors:  Priya Joseph; Maritza M Calderón; Robert H Gilman; Monica L Quispe; Jaime Cok; Eduardo Ticona; Victor Chavez; Juan A Jimenez; Maria C Chang; Martín J Lopez; Carlton A Evans
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Inhibitory effect of aureobasidin A on Toxoplasma gondii.

Authors:  Sabrina Sonda; Giusy Sala; Riccardo Ghidoni; Andrew Hemphill; Jean Pieters
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Diagnosis of Toxoplasma gondii infection in AIDS patients by a tissue-culture technique.

Authors:  C Contini; R Romani; S Magno; S Delia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

7.  Antibody response of HIV-infected patients to latent, cerebral and recently acquired toxoplasmosis.

Authors:  L Machala; M Malý; S Hrdá; H Rozsypal; M Stanková; P Kodym
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 3.267

8.  Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.

Authors:  A Roth; B Roth; K N Arasteh; K Janitschke
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

9.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients.

Authors:  M Dupon; J Cazenave; J L Pellegrin; J M Ragnaud; A Cheyrou; I Fischer; B Leng; J Y Lacut
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.